These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28917518)

  • 1. Genome stability of programmed stem cell products.
    Martin U
    Adv Drug Deliv Rev; 2017 Oct; 120():108-117. PubMed ID: 28917518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).
    Ma N; Shan Y; Liao B; Kong G; Wang C; Huang K; Zhang H; Cai X; Chen S; Pei D; Chen N; Pan G
    J Biol Chem; 2015 May; 290(19):12079-89. PubMed ID: 25795783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming mechanisms influence the maturation of hematopoietic progenitors from human pluripotent stem cells.
    Heo HR; Song H; Kim HR; Lee JE; Chung YG; Kim WJ; Yang SR; Kim KS; Chun T; Lee DR; Hong SH
    Cell Death Dis; 2018 Oct; 9(11):1090. PubMed ID: 30356076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Cell Reprogramming Informed by the Oocyte.
    Gonzalez-Munoz E; Cibelli JB
    Stem Cells Dev; 2018 Jul; 27(13):871-887. PubMed ID: 29737235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Pluripotent Stem Cells: Advances in the Quest for Genetic Stability during Reprogramming Process.
    Turinetto V; Orlando L; Giachino C
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Instability of iPSCs and Challenges in Their Clinical Applications.
    Yoshihara M; Oguchi A; Murakawa Y
    Adv Exp Med Biol; 2019; 1201():23-47. PubMed ID: 31898780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise Review: Molecular Cytogenetics and Quality Control: Clinical Guardians for Pluripotent Stem Cells.
    Rohani L; Johnson AA; Naghsh P; Rancourt DE; Ulrich H; Holland H
    Stem Cells Transl Med; 2018 Dec; 7(12):867-875. PubMed ID: 30218497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
    Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
    Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Array-comparative genomic hybridization characterization of human pluripotent stem cells.
    Elliott AM; Elliott KA; Kammesheidt A
    Methods Mol Biol; 2012; 873():261-7. PubMed ID: 22528361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.
    Laurent LC; Ulitsky I; Slavin I; Tran H; Schork A; Morey R; Lynch C; Harness JV; Lee S; Barrero MJ; Ku S; Martynova M; Semechkin R; Galat V; Gottesfeld J; Izpisua Belmonte JC; Murry C; Keirstead HS; Park HS; Schmidt U; Laslett AL; Muller FJ; Nievergelt CM; Shamir R; Loring JF
    Cell Stem Cell; 2011 Jan; 8(1):106-18. PubMed ID: 21211785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
    Bilic J; Izpisua Belmonte JC
    Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods of Reprogramming to Induced Pluripotent Stem Cell Associated with Chromosomal Integrity and Delineation of a Chromosome 5q Candidate Region for Growth Advantage.
    Sobol M; Raykova D; Cavelier L; Khalfallah A; Schuster J; Dahl N
    Stem Cells Dev; 2015 Sep; 24(17):2032-40. PubMed ID: 25867454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.
    El-Sayed AK; Zhang Z; Zhang L; Liu Z; Abbott LC; Zhang Y; Li B
    Int J Mol Sci; 2014 Nov; 15(12):21840-64. PubMed ID: 25437916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming.
    Chan YS; Göke J; Lu X; Venkatesan N; Feng B; Su IH; Ng HH
    Stem Cells; 2013 Apr; 31(4):682-92. PubMed ID: 23280602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic aberrations in human pluripotent stem cells.
    Bar S; Benvenisty N
    EMBO J; 2019 Jun; 38(12):. PubMed ID: 31088843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.
    Quinlan AR; Boland MJ; Leibowitz ML; Shumilina S; Pehrson SM; Baldwin KK; Hall IM
    Cell Stem Cell; 2011 Oct; 9(4):366-73. PubMed ID: 21982236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic stability of human pluripotent stem cells.
    Lund RJ; Närvä E; Lahesmaa R
    Nat Rev Genet; 2012 Oct; 13(10):732-44. PubMed ID: 22965355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.